AbbVie Inc. is 109.8x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($399.47 B vs $3.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACAD | ABBV |
|---|---|---|
| Market cap | $3.64 B | $399.47 B |
| US-listed rank | #1650 | #28 |
| Revenue (latest FY) | $1.07B | $61.16B |
| Net income (latest FY) | $391.00M | $4.23B |
| Net margin | 36.5% | 6.9% |
| P/E (trailing FY) | 9.3 | 94.5 |
| SEC filings | 1,357 | 1,008 |
AbbVie Inc. is 109.8x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($399.47 B vs $3.64 B).
In their latest fiscal years, ACADIA PHARMACEUTICALS INC reported $1.07B in revenue while AbbVie Inc. reported $61.16B.
Full pages: ACADIA PHARMACEUTICALS INC and AbbVie Inc., or browse the full rankings.